295 related articles for article (PubMed ID: 18433609)
21. New options in diagnosis and management of mycosis fungoides and Sézary syndrome.
Enke CA
Oncology (Williston Park); 2010 May; 24(6):507-8. PubMed ID: 20568591
[No Abstract] [Full Text] [Related]
22. Mycosis Fungoides and Sézary Syndrome: An Update.
Larocca C; Kupper T
Hematol Oncol Clin North Am; 2019 Feb; 33(1):103-120. PubMed ID: 30497668
[TBL] [Abstract][Full Text] [Related]
23. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.
Oh Y; Stoll JR; Moskowitz A; Pulitzer M; Horwitz S; Myskowski P; Noor SJ
J Am Acad Dermatol; 2021 Nov; 85(5):1093-1106. PubMed ID: 33945836
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome.
Shiratori S; Fujimoto K; Nishimura M; Hatanaka KC; Kosugi-Kanaya M; Okada K; Sugita J; Shigematsu A; Hashimoto D; Endo T; Kondo T; Abe R; Hashino S; Matsuno Y; Shimizu H; Teshima T
Hematol Oncol; 2016 Mar; 34(1):9-16. PubMed ID: 25312300
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and management.
Wilcox RA
Am J Hematol; 2014 Aug; 89(8):837-51. PubMed ID: 25042790
[TBL] [Abstract][Full Text] [Related]
26. Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment.
Hoppe RT; Wood GS; Abel EA
Curr Probl Cancer; 1990; 14(6):293-371. PubMed ID: 2245651
[TBL] [Abstract][Full Text] [Related]
27. [Current therapeutic options in Mycosis fungoides and Sézary syndrome].
Albrecht JD; Nicolay JP
Hautarzt; 2022 Jan; 73(1):75-85. PubMed ID: 34988613
[TBL] [Abstract][Full Text] [Related]
28. Mycosis fungoides and sezary syndrome: an update.
Kim EJ; Lin J; Junkins-Hopkins JM; Vittorio CC; Rook AH
Curr Oncol Rep; 2006 Sep; 8(5):376-86. PubMed ID: 16901399
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.
Wilcox RA
Am J Hematol; 2016 Jan; 91(1):151-65. PubMed ID: 26607183
[TBL] [Abstract][Full Text] [Related]
30. [Item no 164: malignant lymphoma: cutaneous lymphoma].
CEDEF
Ann Dermatol Venereol; 2008 Nov; 135(11 Suppl):F160-2. PubMed ID: 18984207
[No Abstract] [Full Text] [Related]
31. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.
Benton EC; Crichton S; Talpur R; Agar NS; Fields PA; Wedgeworth E; Mitchell TJ; Cox M; Ferreira S; Liu P; Robson A; Calonje E; Stefanato CM; Wilkins B; Scarisbrick J; Wain EM; Child F; Morris S; Duvic M; Whittaker SJ
Eur J Cancer; 2013 Sep; 49(13):2859-68. PubMed ID: 23735705
[TBL] [Abstract][Full Text] [Related]
32. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
Wobser M; Goebeler M
Hautarzt; 2019 Oct; 70(10):815-830. PubMed ID: 31511903
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management.
Wilcox RA
Am J Hematol; 2017 Oct; 92(10):1085-1102. PubMed ID: 28872191
[TBL] [Abstract][Full Text] [Related]
34. Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario.
Sanches JA; Cury-Martins J; Abreu RM; Miyashiro D; Pereira J
An Bras Dermatol; 2021; 96(4):458-471. PubMed ID: 34053802
[TBL] [Abstract][Full Text] [Related]
35. [Mycosis fungoides and Sézary syndrome : a systematic review].
André F; Guenova E; Blanchard G
Rev Med Suisse; 2022 Mar; 18(775):578-589. PubMed ID: 35353453
[TBL] [Abstract][Full Text] [Related]
36. Integrating novel systemic therapies for the treatment of mycosis fungoides and Sézary syndrome.
Prince HM; Querfeld C
Best Pract Res Clin Haematol; 2018 Sep; 31(3):322-335. PubMed ID: 30213403
[TBL] [Abstract][Full Text] [Related]
37. Mycosis fungoides and Sézary syndrome.
Jonak C; Tittes J; Brunner PM; Guenova E
J Dtsch Dermatol Ges; 2021 Sep; 19(9):1307-1334. PubMed ID: 34541796
[TBL] [Abstract][Full Text] [Related]
38. Clinical Insights and Emerging Strategies in Managing Cutaneous T-Cell Lymphoma.
Patrone CC; Geskin LJ
J Drugs Dermatol; 2017 May; 16(5):405-412. PubMed ID: 29028854
[TBL] [Abstract][Full Text] [Related]
39. How we treat mycosis fungoides and Sézary syndrome.
Khan N; Noor SJ; Horwitz S
Clin Adv Hematol Oncol; 2021 Sep; 19(9):573-581. PubMed ID: 34495021
[No Abstract] [Full Text] [Related]
40. Mycosis fungoides and Sezary syndrome.
Diamandidou E; Cohen PR; Kurzrock R
Blood; 1996 Oct; 88(7):2385-409. PubMed ID: 8839829
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]